Cross-sectional associations between lifetime use of psychedelic drugs and psychometric measures during the COVID-19 confinement: A transcultural study

This survey study (n=2,974) investigated the relationship between lifetime psychedelic use, personality traits, and mental health during the COVID-19 confinement, and found that regular use was associated with less psychological distress, less peritraumatic stress, and more social support. Psychedelic drug users also scored higher on the novelty-seeking and self-transcendence scales, but lower on cooperativeness.

Abstract

Background: One of the main public health strategies adopted at the beginning of the COVID-19 pandemic consisted of implementing strict lockdowns to stop the transmission of the virus. Despite being an effective measure, the confinement and the associated social isolation create stressful, potentially lengthy situations that have been proven to have several psychological consequences. Given the potential benefits that certain psychedelic drugs have shown for the treatment of psychological disorders, this study aimed to assess the impact of lifetime psychedelic drug use on mental health in relation to the first strict lockdown adopted by various countries (April-July 2020).

Methods: Subjects completed an online survey that inquired about sociodemographic factors, activities, and lifestyle factors during confinement, as well as health and mental health-related factors. Subjects were asked about their lifetime use of psychedelic drugs (MDMA, ayahuasca, psilocybin-containing mushrooms, LSD, peyote, San Pedro, Bufo alvarius or 5-MeO-DMT, and others), being classified as regular users (more than once per six months), occasional users, or non-users. The survey included psychometric tests used to assess psychological distress, peritraumatic stress, social support, coping mechanisms, psychopathological symptoms, and personality. Linear regressions were performed with psychedelic drug users as the independent variable and psychometric factors as the outcomes, while correcting for age, gender, language, religion, spirituality, and use of non-psychedelic drugs.

Results: The study included 2,974 English, Portuguese, and Spanish speakers. On average, respondents were 36 years old and 70% were female. Psychedelic drug use, especially when used regularly, was associated with less psychological distress, less peritraumatic stress, and more social support. Regarding personality measures, psychedelic drug users scored higher on the novelty-seeking and self-transcendence scales, and lower on cooperativeness.

Conclusion: Our findings showed that regular users of psychedelic drugs had less psychological stress and some personality differences when compared to occasional users and non-users. This suggests that either the use of psychedelics might be a protective factor itself or people with certain previous traits are more prone to frequently using psychedelic drugs. Future prospective longitudinal research should investigate the underlying processes observed in this study to develop consistent hypotheses.”

Authors: Dora Révész, Genís Ona, Giordano Rossi, Juliana M. Rocha, Rafael G. Dos Santos, Jaime E. Hallak, Miguel Ángel Alcázar-Córcoles & José C. Bouso

Summary of Cross-sectional associations between lifetime use of psychedelic drugs and psychometric measures during the COVID-19 confinement: A transcultural study

Introduction

The new 2019 coronavirus, closely related to the severe acute respiratory syndrome (SARS)-CoV and the Middle East respiratory syndrome (MERS)-CoV, has spread globally following the outbreak of the virus between late December 2019 and early January 2020.

Medical experts have advised governments to implement social distancing policies in their countries to hamper the virus’s transmission. However, quarantine causes its own set of problems, particularly associated with mental health and well-being.

To access this content, you must purchase one of the following memberships: Sprout Membership, Pro Membership, Pro Membership Unlimited, Business Membership or Business Membership Unlimited. The membership will give you access to exclusive data, including summaries of psychedelic research papers, extended company info, and our member-only visualisations. Save yourself multiple hours each week by accessing Blossom’s resource library.

Authors

Authors associated with this publication with profiles on Blossom

José Carlos Bouso
José Carlos Bouso is a Clinical Psychologist with a PhD in Pharmacology and is the current Scientific Director at ICEERS.

PDF of Cross-sectional associations between lifetime use of psychedelic drugs and psychometric measures during the COVID-19 confinement: A transcultural study